Illumina, Inc. (ILMN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$207.08
+2.92%
Mkt Cap $33.02B
Analyst Ratings
Buy
14
Hold
5
Sell
5
Price Target (71 analysts)
$156.27
Range $122.00 – $200.00
Implied Upside
-24.5%
Consensus $156.27 vs current $207.08